Can Bioactive Food Substances Contribute to Cystic Fibrosis-Related Cardiovascular Disease Prevention?
暂无分享,去创建一个
M. Moscalu | E. Țarcă | L. Butnariu | E. Cojocaru | L. Trandafir | Maria Magdalena Leon Constantin | O. Temneanu | O. Frăsinariu | Iuliana Magdalena Stârcea | Ș. Moisă | Alina Sinziana Melinte Popescu | Marian George Melinte Popescu | I. Stârcea | Ș. Moisa
[1] Zhongyun Zhao,et al. The impacts of vitamin D supplementation in adults with metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials , 2022, Frontiers in Pharmacology.
[2] A. Moran,et al. Coronary artery disease in patients with cystic fibrosis – A case series and review of the literature , 2022, Journal of clinical & translational endocrinology.
[3] G. Dodi,et al. Tackling Dyslipidemia in Obesity from a Nanotechnology Perspective , 2022, Nutrients.
[4] S. Lorkowski,et al. Vitamin E and Metabolic Health: Relevance of Interactions with Other Micronutrients , 2022, Antioxidants.
[5] G. Parisi,et al. Cystic Fibrosis and Oxidative Stress: The Role of CFTR , 2022, Molecules.
[6] P. Saneei,et al. Serum 25-hydroxyvitamin D levels and dyslipidemia: a systematic review and dose-response meta-analysis of epidemiologic studies. , 2022, Nutrition reviews.
[7] A. Sahebkar,et al. Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A Position Paper of the International Lipid Expert Panel. , 2022, Pharmacological research.
[8] H. Randeva,et al. Implications of Resveratrol in Obesity and Insulin Resistance: A State-of-the-Art Review , 2022, Nutrients.
[9] Lu Han,et al. Association between Vitamin D Deficiency and Levels of Renin and Angiotensin in Essential Hypertension , 2022, International journal of clinical practice.
[10] E. Ramírez‐Moreno,et al. Role of Bioactive Compounds in Obesity: Metabolic Mechanism Focused on Inflammation , 2022, Foods.
[11] Srujana Medithi,et al. Nutraceutical Approach for the Management of Cystic Fibrosis , 2022, Current Nutrition & Food Science.
[12] S. Ranganathan,et al. Identifying and preventing cardiovascular disease in patients with cystic fibrosis , 2022, Nature Cardiovascular Research.
[13] B. Strandvik. Nutrition in Cystic Fibrosis—Some Notes on the Fat Recommendations , 2022, Nutrients.
[14] A. Tindall,et al. Utilization of the Healthy Eating Index in Cystic Fibrosis , 2022, Nutrients.
[15] C. Y. Ooi,et al. Intestinal Inflammation and Alterations in the Gut Microbiota in Cystic Fibrosis: A Review of the Current Evidence, Pathophysiology and Future Directions , 2022, Journal of clinical medicine.
[16] C. Y. Ooi,et al. What Do We Know about the Microbiome in Cystic Fibrosis? Is There a Role for Probiotics and Prebiotics? , 2022, Nutrients.
[17] E. Schelbert,et al. Cardiac involvement in cystic fibrosis evaluated using cardiopulmonary magnetic resonance , 2022, The International Journal of Cardiovascular Imaging.
[18] A. Meissner,et al. Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammation , 2021, Frontiers in Immunology.
[19] A. Orekhov,et al. Atherosclerosis amelioration by allicin in raw garlic through gut microbiota and trimethylamine-N-oxide modulation , 2021, NPJ biofilms and microbiomes.
[20] E. Țarcă,et al. Genetic Modifying Factors of Cystic Fibrosis Phenotype: A Challenge for Modern Medicine , 2021, Journal of Clinical Medicine.
[21] D. Kirk,et al. Acute ST-elevation myocardial infarction in two young women with cystic fibrosis and cystic fibrosis-related diabetes , 2021, Journal of Cystic Fibrosis.
[22] A. Moheet,et al. Obesity in cystic fibrosis , 2021, Journal of clinical & translational endocrinology.
[23] Anas M. Saad,et al. Vitamin K2—a neglected player in cardiovascular health: a narrative review , 2021, Open Heart.
[24] M. Konstan,et al. Increasing life expectancy in cystic fibrosis: Advances and challenges , 2021, Pediatric pulmonology.
[25] N. Dhalla,et al. Effectiveness of Some Vitamins in the Prevention of Cardiovascular Disease: A Narrative Review , 2021, Frontiers in Physiology.
[26] I. A. Abdelhaleem,et al. The effects of resveratrol on glycemic control and cardiometabolic parameters in patients with T2DM: A systematic review and meta-analysis. , 2021, Medicina clinica.
[27] Samuel I. Miller,et al. Infants with cystic fibrosis have altered fecal functional capacities with potential clinical and metabolic consequences , 2021, BMC Microbiology.
[28] S. Kundu,et al. Herbs and their bioactive ingredients in cardio-protection: Underlying molecular mechanisms and evidences from clinical studies. , 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[29] V. Stallings,et al. The Impact of Highly Effective CFTR Modulators on Growth and Nutrition Status , 2021, Nutrients.
[30] A. Tjønneland,et al. Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study , 2021, Journal of the American Heart Association.
[31] Pousette Hamid,et al. Cardiovascular System Involvement in Cystic Fibrosis , 2021, Cureus.
[32] J. Taylor-Cousar,et al. Cardiovascular complications in cystic fibrosis: A review of the literature. , 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[33] P. Palange,et al. Overweight and obesity in adults with cystic fibrosis: An Italian multicenter cohort study. , 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[34] S. Asgary,et al. Effect of Beetroot Consumption on Serum Lipid Profile: A Systematic Review and Meta-Analysis. , 2021, Current problems in cardiology.
[35] Carlos J. Rodriguez,et al. Metabolically Healthy Obesity Redefined. , 2021, JAMA network open.
[36] Zhuxian Zhang,et al. Inverse association between dietary vitamin A intake and new-onset hypertension. , 2021, Clinical nutrition.
[37] F. Geng,et al. Plant-Based Foods and Their Bioactive Compounds on Fatty Liver Disease: Effects, Mechanisms, and Clinical Application , 2021, Oxidative medicine and cellular longevity.
[38] S. Esposito,et al. Dysbiosis in Pediatrics Is Associated with Respiratory Infections: Is There a Place for Bacterial-Derived Products? , 2021, Microorganisms.
[39] T. Sferra,et al. Impact of Altered Gut Microbiota and Its Metabolites in Cystic Fibrosis , 2021, Metabolites.
[40] L. Nováková,et al. Vitamin C—Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination , 2021, Nutrients.
[41] G. Santulli,et al. Vitamin C and Cardiovascular Disease: An Update , 2020, Antioxidants.
[42] M. Boccellino,et al. Anti-Obesity Effects of Polyphenol Intake: Current Status and Future Possibilities , 2020, International journal of molecular sciences.
[43] S. Ima-Nirwana,et al. Vitamin C: A Review on its Role in the Management of Metabolic Syndrome , 2020, International journal of medical sciences.
[44] C. McDonald,et al. Dietary Macronutrient Distribution and Nutrition Outcomes in Persons with Cystic Fibrosis: An Evidence Analysis Center Systematic Review. , 2020, Journal of the Academy of Nutrition and Dietetics.
[45] E. Sanders,et al. Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment. , 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[46] M. Abbasalizad Farhangi,et al. Does synbiotic supplementation affect the quality of life in children with cystic fibrosis? A pilot randomized controlled clinical trial , 2020, BMC Nutrition.
[47] A. Mejias,et al. Age and environmental exposures influence the fecal bacteriome of young children with cystic fibrosis , 2020, Pediatric pulmonology.
[48] Deborah A. Corey,et al. Resveratrol restores intracellular transport in cystic fibrosis epithelial cells. , 2020, American journal of physiology. Lung cellular and molecular physiology.
[49] M. Ikram,et al. The Pharmacological Activity, Biochemical Properties, and Pharmacokinetics of the Major Natural Polyphenolic Flavonoid: Quercetin , 2020, Foods.
[50] J. Wells,et al. Pulmonary artery enlargement is associated with pulmonary hypertension and decreased survival in severe cystic fibrosis: A cohort study , 2020, PloS one.
[51] G. Lam,et al. The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis , 2020, Annals of the American Thoracic Society.
[52] Samuel I. Miller,et al. Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure , 2020, Nature Network Boston.
[53] A. Bonhoure,et al. Overweight, obesity and significant weight gain in adult patients with cystic fibrosis association with lung function and cardiometabolic risk factors. , 2020, Clinical nutrition.
[54] John C. Yoon,et al. Nutritional excess in cystic fibrosis: the skinny on obesity. , 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[55] T. Thomas,et al. Gut Microbiota in Children With Cystic Fibrosis: A Taxonomic and Functional Dysbiosis , 2019, Scientific Reports.
[56] Gongshe Yang,et al. Allicin Improves Metabolism in High-Fat Diet-Induced Obese Mice by Modulating the Gut Microbiota , 2019, Nutrients.
[57] P. Palange,et al. Renal involvement and metabolic alterations in adults patients affected by cystic fibrosis , 2019, Journal of Translational Medicine.
[58] A. Moran,et al. Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: A single-center analysis. , 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[59] J. López-Miranda,et al. The Fluid Aspect of the Mediterranean Diet in the Prevention and Management of Cardiovascular Disease and Diabetes: The Role of Polyphenol Content in Moderate Consumption of Wine and Olive Oil , 2019, Nutrients.
[60] A. Moran,et al. Cystic fibrosis related diabetes: Nutrition and growth considerations. , 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[61] L. Soldati,et al. Curcumin and Type 2 Diabetes Mellitus: Prevention and Treatment , 2019, Nutrients.
[62] Wentao Xu,et al. Allicin Regulates Energy Homeostasis through Brown Adipose Tissue , 2019, bioRxiv.
[63] M. Holick,et al. Vitamin D for skeletal and non-skeletal health: What we should know. , 2019, Journal of clinical orthopaedics and trauma.
[64] G. Dodi,et al. Current Practices and Potential Nanotechnology Perspectives for Pain Related to Cystic Fibrosis , 2019, Journal of clinical medicine.
[65] C. Severi,et al. Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified , 2019, World journal of gastroenterology.
[66] C. Colombo,et al. Challenges with optimizing nutrition in cystic fibrosis , 2019, Expert review of respiratory medicine.
[67] M. Boon,et al. The Relative Contribution of Food Groups to Macronutrient Intake in Children with Cystic Fibrosis: A European Multicenter Assessment. , 2019, Journal of the Academy of Nutrition and Dietetics.
[68] Corrie M. Whisner,et al. Six-Week High-Fat Diet Alters the Gut Microbiome and Promotes Cecal Inflammation, Endotoxin Production, and Simple Steatosis without Obesity in Male Rats. , 2019, Lipids.
[69] M. Suico,et al. Curcumin Down-Regulates Toll-Like Receptor-2 Gene Expression and Function in Human Cystic Fibrosis Bronchial Epithelial Cells. , 2019, Biological & pharmaceutical bulletin.
[70] M. Surette,et al. Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation , 2018, Scientific Reports.
[71] C. Collins,et al. Dietary intake of energy-dense, nutrient-poor and nutrient-dense food sources in children with cystic fibrosis. , 2018, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[72] Hojjat Allah Abbaszadeh,et al. Resveratrol: A miraculous natural compound for diseases treatment , 2018, Food science & nutrition.
[73] S. Lochyński,et al. Polyunsaturated Fatty Acids and Their Potential Therapeutic Role in Cardiovascular System Disorders—A Review , 2018, Nutrients.
[74] T. Kotsimbos,et al. Subclinical Left Ventricular Dysfunction is Influenced by Genotype Severity in Patients with Cystic Fibrosis , 2018, Clinical medicine insights. Circulatory, respiratory and pulmonary medicine.
[75] C. Ingraham,et al. An Interventionalist's Guide to Hemoptysis in Cystic Fibrosis. , 2018, Radiographics : a review publication of the Radiological Society of North America, Inc.
[76] A. Kurilshikov,et al. Environment dominates over host genetics in shaping human gut microbiota , 2018, Nature.
[77] Samuel I. Miller,et al. Adaptation of commensal proliferating Escherichia coli to the intestinal tract of young children with cystic fibrosis , 2018, Proceedings of the National Academy of Sciences.
[78] J. Tuomilehto,et al. Functional Foods and Lifestyle Approaches for Diabetes Prevention and Management , 2017, Nutrients.
[79] Yu-Chiang Hung,et al. Polyphenols and Oxidative Stress in Atherosclerosis-Related Ischemic Heart Disease and Stroke , 2017, Oxidative medicine and cellular longevity.
[80] T. Yi,et al. The Beneficial Effects of Quercetin, Curcumin, and Resveratrol in Obesity , 2017, Oxidative medicine and cellular longevity.
[81] M. Orrell,et al. Loneliness, Social Integration, and Incident Dementia Over 6 Years: Prospective Findings From the English Longitudinal Study of Ageing , 2017, The journals of gerontology. Series B, Psychological sciences and social sciences.
[82] F. Fogacci,et al. Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach. , 2017, Food & function.
[83] C. Hill,et al. The altered gut microbiota in adults with cystic fibrosis , 2017, BMC Microbiology.
[84] A. Linneberg,et al. Vitamin D, Cardiovascular Disease and Risk Factors. , 2017, Advances in experimental medicine and biology.
[85] T. Ma,et al. Role of Quercetin in Modulating Chloride Transport in the Intestine , 2016, Front. Physiol..
[86] R. Levy,et al. Coronary artery disease in cystic fibrosis: An emerging concern? , 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[87] J. Kelsen,et al. Advances in Gut Microbiome Research and Relevance to Pediatric Diseases. , 2016, The Journal of pediatrics.
[88] A. Colletti,et al. Role of phytochemicals in the management of metabolic syndrome. , 2016, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[89] E. Saloux,et al. Heart involvement in cystic fibrosis: A specific cystic fibrosis-related myocardial changes? , 2016, Respiratory medicine.
[90] O. Chun,et al. Vitamin C and Heart Health: A Review Based on Findings from Epidemiologic Studies , 2016, International journal of molecular sciences.
[91] Subramani Parasuraman,et al. Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid , 2016, Pharmacognosy reviews.
[92] J. Wells,et al. Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study , 2016, The Lancet. Respiratory medicine.
[93] B. Strandvik,et al. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. , 2016, Clinical nutrition.
[94] T. Thomas,et al. Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis , 2016, Scientific Reports.
[95] Samuel I. Miller,et al. Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis , 2016, Scientific Reports.
[96] Peter Dawyndt,et al. Faecal proteomics: A tool to investigate dysbiosis and inflammation in patients with cystic fibrosis. , 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[97] K. Ried. Garlic Lowers Blood Pressure in Hypertensive Individuals, Regulates Serum Cholesterol, and Stimulates Immunity: An Updated Meta-analysis and Review. , 2016, The Journal of nutrition.
[98] N. Bradbury,et al. Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis , 2016, Journal of genetic syndromes & gene therapy.
[99] S. Srinivasan,et al. Intestinal Dysbiosis Contributes to the Delayed Gastrointestinal Transit in High-Fat Diet Fed Mice , 2016, Cellular and molecular gastroenterology and hepatology.
[100] Kai Jiang,et al. The impact of Cystic Fibrosis Transmembrane Regulator Disruption on cardiac function and stress response. , 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[101] A. Wiktorowska-Owczarek,et al. PUFAs: Structures, Metabolism and Functions. , 2015, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.
[102] E. Murphy,et al. Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk , 2015, Current opinion in clinical nutrition and metabolic care.
[103] A. Brasch,et al. Strain rate echocardiography uncovers subclinical left ventricular dysfunction in cystic fibrosis. , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[104] H. Schillers,et al. Cystic fibrosis transmembrane conductance regulator is involved in polyphenol-induced swelling of the endothelial glycocalyx. , 2015, Nanomedicine : nanotechnology, biology, and medicine.
[105] Zhe Yang,et al. Bioactive Food Components as Dietary Intervention for Cystic Fibrosis. , 2015, Current Drug Targets.
[106] D. Ward,et al. 16S community profiling identifies proton pump inhibitor related differences in gastric, lung, and oropharyngeal microflora. , 2015, The Journal of pediatrics.
[107] S. Jee,et al. Association between idiopathic pulmonary fibrosis and coronary artery disease: a case-control study and cohort analysis. , 2015, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[108] L. Lands,et al. The Emergence of Polyphenols in the Potentiation of Treatment Modality in Cystic Fibrosis , 2015 .
[109] I. Miron,et al. Psychosocial Implications of Childhood Obesity , 2015 .
[110] B. Morrissey,et al. Inflammation, oxidative stress, and cardiovascular disease risk factors in adults with cystic fibrosis. , 2014, Free radical biology & medicine.
[111] N. Deutz,et al. Protein is an important but undervalued macronutrient in the nutritional care of patients with cystic fibrosis , 2014, Current opinion in clinical nutrition and metabolic care.
[112] Matthew J. Thompson,et al. The effect of green tea on blood pressure and lipid profile: a systematic review and meta-analysis of randomized clinical trials. , 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[113] C. Uiterwaal,et al. The association between lung function and arterial stiffness in young childhood , 2014, European Respiratory Journal.
[114] L. Morelli,et al. Disrupted Intestinal Microbiota and Intestinal Inflammation in Children with Cystic Fibrosis and Its Restoration with Lactobacillus GG: A Randomised Clinical Trial , 2014, PloS one.
[115] J. Powell,et al. Vitamin D and cardiovascular disease. , 2014, Circulation research.
[116] M. Budoff,et al. Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease , 2013, Annals of the rheumatic diseases.
[117] I. Căruntu,et al. Hepatic steatosis background in chronic hepatitis B and C - significance of similarities and differences. , 2014, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.
[118] P. Vandamme,et al. Amoxicillin-clavulanic acid resistance in fecal Enterobacteriaceae from patients with cystic fibrosis and healthy siblings. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[119] Attila Vereczkey,et al. Folate Deficiency and Folic Acid Supplementation: The Prevention of Neural-Tube Defects and Congenital Heart Defects , 2013, Nutrients.
[120] C. Yosefy,et al. Nutritional Recommendations for Cardiovascular Disease Prevention , 2013, Nutrients.
[121] G. Derosa,et al. Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects. , 2013, Nutrition research.
[122] W. Paulus,et al. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. , 2013, Journal of the American College of Cardiology.
[123] A. Feizi,et al. Does Quercetin Improve Cardiovascular Risk factors and Inflammatory Biomarkers in Women with Type 2 Diabetes: A Double-blind Randomized Controlled Clinical Trial , 2013, International journal of preventive medicine.
[124] Y. Sohma,et al. Curcumin and genistein: the combined effects on disease-associated CFTR mutants and their clinical implications. , 2013, Current pharmaceutical design.
[125] M. Lucarelli,et al. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Allelic Variants Relate to Shifts in Faecal Microbiota of Cystic Fibrosis Patients , 2013, PloS one.
[126] S. Poore,et al. Evidence of vascular endothelial dysfunction in young patients with cystic fibrosis. , 2013, Chest.
[127] B. Morrissey,et al. Joining the crowd: cystic fibrosis and cardiovascular disease risk factors. , 2013, Chest.
[128] S. Stanojevic,et al. Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: a population-based cohort study. , 2013, The American journal of clinical nutrition.
[129] C. Tangney,et al. Polyphenols, Inflammation, and Cardiovascular Disease , 2013, Current Atherosclerosis Reports.
[130] G. Ferns,et al. Effects of Supplementation with Curcuminoids on Dyslipidemia in Obese Patients: A Randomized Crossover Trial , 2013, Phytotherapy research : PTR.
[131] A. Baño-Rodrigo,et al. Right ventricular dysfunction in adolescents with mild cystic fibrosis. , 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[132] N. Regamey,et al. Increased arterial stiffness in children with cystic fibrosis , 2012, European Respiratory Journal.
[133] P. Seddon,et al. A fat lot of good: balance and trends in fat intake in children with cystic fibrosis. , 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[134] S. Ozkanlar,et al. Antioxidant vitamins in atherosclerosis--animal experiments and clinical studies. , 2012, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.
[135] David J Williams,et al. New Insights About Vitamin D and Cardiovascular Disease , 2011, Annals of Internal Medicine.
[136] E. Saloux,et al. Myocardial strain assessment in cystic fibrosis. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[137] M. Yasui,et al. Curcumin and genistein additively potentiate G551D-CFTR. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[138] T. Münzel,et al. Oxidative stress and endothelial dysfunction: Therapeutic implications , 2011, Annals of medicine.
[139] Y. Xiang,et al. Cardiomyocytes with disrupted CFTR function require CaMKII and Ca2+‐activated Cl− channel activity to maintain contraction rate , 2010, The Journal of physiology.
[140] F. Perrin,et al. Ischaemic heart disease - a new issue in cystic fibrosis? , 2010, Journal of the Royal Society of Medicine.
[141] V. Georgiopoulou,et al. Metabolic abnormalities in adults with cystic fibrosis , 2008, Respirology.
[142] I. Petrache,et al. CFTR regulation of intracellular pH and ceramides is required for lung endothelial cell apoptosis. , 2009, American journal of respiratory cell and molecular biology.
[143] R. K. Knight,et al. Increased augmentation index in patients with cystic fibrosis , 2009, European Respiratory Journal.
[144] G. Russo. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. , 2009, Biochemical pharmacology.
[145] K. Pandey,et al. Plant polyphenols as dietary antioxidants in human health and disease , 2009, Oxidative medicine and cellular longevity.
[146] R. Koerfer,et al. Protective and toxic effects of vitamin D on vascular calcification: clinical implications. , 2008, Molecular aspects of medicine.
[147] Dongmin Liu,et al. Green tea catechins and cardiovascular health: an update. , 2008, Current medicinal chemistry.
[148] E. Evans,et al. Effects of cocoa flavanols on risk factors for cardiovascular disease. , 2008, Asia Pacific journal of clinical nutrition.
[149] G. Onady,et al. An adult cystic fibrosis patient presenting with persistent dyspnea: case report , 2006, BMC pulmonary medicine.
[150] Peter Libby,et al. Inflammation and cardiovascular disease mechanisms. , 2006, The American journal of clinical nutrition.
[151] P. Zeitlin,et al. Modulation of deltaF508 cystic fibrosis transmembrane regulator trafficking and function with 4-phenylbutyrate and flavonoids. , 2004, American journal of respiratory cell and molecular biology.
[152] K. Du,et al. Curcumin, a Major Constituent of Turmeric, Corrects Cystic Fibrosis Defects , 2004, Science.
[153] T. Koelling,et al. Left ventricular diastolic function in patients with advanced cystic fibrosis. , 2003, Chest.
[154] Leslie A. Smith,et al. Long-Term Vitamin C Treatment Increases Vascular Tetrahydrobiopterin Levels and Nitric Oxide Synthase Activity , 2003, Circulation research.
[155] G. Fowkes,et al. Exercise, Inflammation and Cardiovascular Disease , 2003, The Journal of physiology.
[156] P. Whelton,et al. Serum Antioxidant Vitamins and Blood Pressure in the United States Population , 2002, Hypertension.
[157] Takao Yokota,et al. Plant foods and herbal sources of resveratrol. , 2002, Journal of agricultural and food chemistry.
[158] K. Webb,et al. The heart in cystic fibrosis. , 2002, Journal of the Royal Society of Medicine.
[159] N. Florea,et al. Right ventricular dysfunction in adult severe cystic fibrosis. , 2000, Chest.
[160] J. Schwartz,et al. Role of polyunsaturated fatty acids in lung disease. , 2000, The American journal of clinical nutrition.
[161] J. Farmer,et al. Tumor Necrosis Factor-α: A Mediator of Disease Progression in the Failing Human Heart , 1999 .
[162] R. Heller,et al. l-Ascorbic Acid Potentiates Nitric Oxide Synthesis in Endothelial Cells* , 1999, The Journal of Biological Chemistry.
[163] V. Palace,et al. Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease. , 1999, Free radical biology & medicine.
[164] B. Wilcken,et al. B Vitamins and Homocysteine in Cardiovascular Disease and Aging , 1998, Annals of the New York Academy of Sciences.
[165] E. Trulock,et al. Right and left ventricular dysfunction in patients with severe pulmonary disease. , 1998, Chest.
[166] C. Cooper,et al. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people , 1995, BMJ.
[167] P. Ambrosi,et al. [Left ventricular involvement in mucoviscidosis after 2 years of age]. , 1993, Archives francaises de pediatrie.
[168] J. Kanga,et al. Changes in left ventricular diastolic filling patterns by Doppler echocardiography in cystic fibrosis. , 1991, Chest.
[169] L. Benson,et al. Radionuclide assessment of right and left ventricular function during bicycle exercise in young patients with cystic fibrosis. , 1984, The American review of respiratory disease.
[170] P. Alderson,et al. Noninvasive evaluation of ventricular function in cystic fibrosis. , 1979, The Journal of pediatrics.
[171] E. Braunwald. Heart Disease: A Textbook of Cardiovascular Medicine , 1992, Annals of Internal Medicine.
[172] A. Moss,et al. Preatherosclerotic aortic lesions in cystic fibrosis. , 1979, The Journal of pediatrics.
[173] N. K. Murty,et al. Vitamin C (ascorbic acid). , 1979, Methods in enzymology.